SCHEMBL94263

SCHEMBL94263

O=C1c2c(O)cc(O)cc2O[C@H](c2cc(O)c3c(c2)[C@@H](CO)[C@H](c2ccc(O)c(O)c2)O3)[C@H]1O

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLCO1B3 Q9NPD5 4/20 0.82
SLCO1B1 Q9Y6L6 4/20 0.82
SLCO2B1 O94956 3/20 0.82
CYP3A4 P08684 4/20 0.71
ALOX15 P16050 4/20 0.71
MAPT P10636 3/20 0.71
HSD17B10 Q99714 3/20 0.71
RECQL P46063 2/20 0.71
SOST Q9BQB4 2/20 0.71
MEN1 O00255 2/20 0.71
KMT2A Q03164 2/20 0.71
KDM4E B2RXH2 2/20 0.71
GAA P10253 2/20 0.71
ALOX12 P18054 2/20 0.71
HIF1A Q16665 2/20 0.71
POLB P06746 1/20 0.71
CYP1A2 P05177 1/20 0.71
NFKB1 P19838 1/20 0.71
MAPK1 P28482 1/20 0.71
SYNJ2 O15056 3/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Silicristin A SCHEMBL971442 0.90 SLCO1B3 (1.00) SLCO1B3SLCO1B1SLCO2B1CYP3A4ALOX15
Silicristin A SCHEMBL10049339 0.90 SLCO1B3 (1.00) SLCO1B3SLCO1B1SLCO2B1CYP3A4ALOX15
Silicristin SCHEMBL29388135 0.90 SLCO1B3 (1.00) SLCO1B3SLCO1B1SLCO2B1CYP3A4ALOX15
Silicristin A SCHEMBL29977624 0.90 SLCO1B3 (1.00) SLCO1B3SLCO1B1SLCO2B1CYP3A4ALOX15
Silicristin A SCHEMBL12871270 0.90 SLCO1B3 (1.00) SLCO1B3SLCO1B1SLCO2B1CYP3A4ALOX15
Silicristin A SCHEMBL4654076 0.90 SLCO1B3 (1.00) SLCO1B3SLCO1B1SLCO2B1CYP3A4ALOX15
Silicristin B SCHEMBL20152103 0.90 SLCO1B3 (1.00) SLCO1B3SLCO1B1SLCO2B1CYP3A4ALOX15
Silicristin B SCHEMBL29420864 0.90 SLCO1B3 (1.00) SLCO1B3SLCO1B1SLCO2B1CYP3A4ALOX15
Silicristin A SCHEMBL22571311 0.90 SLCO1B3 (1.00) SLCO1B3SLCO1B1SLCO2B1CYP3A4ALOX15
SCHEMBL17663665 0.88 SLCO1B3 (0.90) SLCO1B3SLCO1B1SLCO2B1CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2141 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122031742-A Starch film slow-release patch for promoting wound healing and preparation method thereof 咸阳职业技术学院 2026-05-15 CN claimed
EP-4734943-A1 PERSONAL CARE COMPOSITION COMPRISING A CARBOXYMETHYL CYSTEINE COMPOUND AND A SILYMARIN COMPOUND Unilever IP Holdings B.V. (NL) 2026-05-06 EP claimed
US-20260091073-A1 COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME CYDEX PHARMACEUTICALS INC (US) 2026-04-02 US claimed
EP-4663188-A1 USE OF SILYBUM MARIANUM PHARMACEUTICAL COMPOSITION IN PREPARATION OF DRUGS FOR TREATING FATTY LIVER DISEASES Health and Happiness (H&H) Hong Kong Limited (HK) 2025-12-17 EP claimed
EP-4620534-A2 COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME CyDex Pharmaceuticals, Inc. (US) 2025-09-24 EP claimed
US-12390506-B2 Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same CYDEX PHARMACEUTICALS, INC. (US) 2025-08-19 US claimed
EP-3939582-B1 COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME CYDEX PHARMACEUTICALS INC (US) 2025-04-30 EP claimed
CN-119770483-A Application of pharmaceutical composition in preparation of medicine for treating neurodegenerative diseases 合生元(广州)健康产品有限公司 2025-04-08 CN claimed
WO-2025024478-A1 COMPOSITIONS FOR THE MODULATION OF TASTE IXORA SCIENTIFIC INC. (US) 2025-01-30 WO claimed
WO-2025002724-A1 PERSONAL CARE COMPOSITION COMPRISING A CARBOXYMETHYL CYSTEINE COMPOUND AND A SILYMARIN COMPOUND UNILEVER IP HOLDINGS B.V. (NL) 2025-01-02 WO claimed
CN-1111506-A Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals INDENA SPA (IT) 1995-11-15 CN claimed
EP-0659402-A2 Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals INDENA S.p.A. (IT) 1995-06-28 EP claimed
EP-0300282-B1 PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING COMPLEXES OF FLAVANOLIGNANS WITH PHOSPHOLIPIDS INDENA S.p.A. (IT) 1992-11-11 EP claimed
EP-0209037-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING FLAVANOLIGNANES AND PHOSPHOLIPIDS AS ACTIVE PRINCIPLES I D B HOLDING S.P.A. (IT) 1990-02-28 EP claimed
US-4895839-A ANTIEDEMIC, SKIN PROTECTION INDENZA S.p.A. (IT) 1990-01-23 US claimed
EP-0209038-B1 COMPLEXES OF FLAVANOLIGNANES WITH PHOSPHOLIPIDS, PREPARATION THEREOF AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS I D B HOLDING S.P.A. (IT) 1989-09-20 EP claimed
EP-0300282-A1 Pharmaceutical and cosmetic compositions containing complexes of flavanolignans with phospholipids INDENA S.p.A. (IT) 1989-01-25 EP claimed
US-4764508-A Complexes of flavanolignans with phospholipids, preparation thereof and associated pharmaceutical compositions INVERNI DELLA BEFFA S.P.A. (IT) 1988-08-16 US claimed
EP-0209038-A1 Complexes of flavanolignanes with phospholipids, preparation thereof and associated pharmaceutical compositions I D B HOLDING S.P.A. (IT) 1987-01-21 EP claimed
EP-0209037-A1 Pharmaceutical compositions containing flavanolignanes and phospholipids as active principles I D B HOLDING S.P.A. (IT) 1987-01-21 EP claimed